Scynexis (SCYX) Other financing activities (2014 - 2025)

Scynexis (SCYX) reported Other financing activities of $116000.0 for Q4 2025, down 25.16% on a YoY basis from $155000.0 in Q4 2024, and up 5.45% quarter-over-quarter from $110000.0 in Q1 2025.

Scynexis (SCYX) Other financing activities (2014 - 2025) Analysis & Trends

Scynexis has reported Other financing activities for 8 years, with the latest figure at $116000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 25.16% year-over-year to $116000.0; the trailing twelve-month figure through Mar 2026 stood at $116000.0 (down 56.23% YoY), and the FY2025 full-year result was $226000.0, up 15.9% from the prior year.
  • Other financing activities for Q4 2025 stood at $116000.0, up from $110000.0 in the prior quarter.
  • The five-year high for Other financing activities was $155000.0 in Q4 2024, with the low at $40000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Scynexis 225.23 Mn 165.97 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 116,000.00
Dec 31, 2025 116,000.00
Mar 31, 2025 110,000.00
Mar 31, 2025 110,000.00
Dec 31, 2024 155,000.00
Dec 31, 2024 155,000.00
Mar 31, 2024 40,000.00
Mar 31, 2024 40,000.00
Sep 30, 2020 32,000.00
Sep 30, 2020 32,000.00
Jun 30, 2020 462,000.00
Jun 30, 2020 462,000.00
Jun 30, 2019 110,000.00
Jun 30, 2019 110,000.00
Mar 31, 2019 1.14 Mn
Mar 31, 2019 1.14 Mn
Sep 30, 2017 120,000.00
Sep 30, 2017 120,000.00
Jun 30, 2017 60,000.00
Jun 30, 2017 60,000.00